What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Disease
Internal medicine, Acquired immunodeficiency syndrome, Immunology, Surgery and Odds ratio are his primary areas of study.
His work on Urinary system and Pharmacotherapy as part of general Internal medicine research is frequently linked to Aciclovir and Adult women, bridging the gap between disciplines.
His study in the fields of Serodiscordant under the domain of Acquired immunodeficiency syndrome overlaps with other disciplines such as Pre-exposure prophylaxis.
His work focuses on many connections between Serodiscordant and other disciplines, such as Emtricitabine, that overlap with his field of interest in Placebo and Randomized controlled trial.
The study incorporates disciplines such as Condom, Genital ulcer, Incidence and Risk factor in addition to Immunology.
His research in Surgery intersects with topics in Bacteriuria, Sulfamethoxazole, Kidney disease and Trimethoprim.
His most cited work include:
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2088 citations)
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2088 citations)
- Cofactors in Male-Female Sexual Transmission of Human Immunodeficiency Virus Type 1 (651 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Urinary system and Surgery.
As a member of one scientific family, Allan R. Ronald mostly works in the field of Internal medicine, focusing on Trimethoprim and, on occasion, Sulfamethoxazole.
His studies deal with areas such as Sex organ, Syphilis, Incidence and Sexually transmitted disease as well as Immunology.
His biological study deals with issues like Viral disease, which deal with fields such as Epidemiology.
His Urinary system research incorporates themes from Urine, Antimicrobial, Intensive care medicine and Urology.
His Randomized controlled trial research is multidisciplinary, relying on both Serodiscordant and Emtricitabine.
He most often published in these fields:
- Internal medicine (44.07%)
- Immunology (26.10%)
- Acquired immunodeficiency syndrome (20.68%)
What were the highlights of his more recent work (between 2009-2021)?
- Internal medicine (44.07%)
- Pre-exposure prophylaxis (9.15%)
- Serodiscordant (8.81%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Pre-exposure prophylaxis, Serodiscordant, Emtricitabine and Randomized controlled trial.
Allan R. Ronald has included themes like Transmission and Physical therapy in his Internal medicine study.
Allan R. Ronald has included themes like Clinical trial, Cohort study, Demography, Gynecology and Hazard ratio in his Serodiscordant study.
The concepts of his Emtricitabine study are interwoven with issues in Interquartile range, Bone remodeling, Tubulopathy, Placebo and Physiology.
His Randomized controlled trial study combines topics in areas such as Acquired immunodeficiency syndrome and Tenofovir.
His Acquired immunodeficiency syndrome study frequently draws connections between related disciplines such as Pediatrics.
Between 2009 and 2021, his most popular works were:
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2088 citations)
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2088 citations)
- Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. (447 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Disease
His primary areas of study are Internal medicine, Pre-exposure prophylaxis, Emtricitabine, Randomized controlled trial and Placebo.
His Internal medicine study combines topics from a wide range of disciplines, such as Viral load and Immunology.
Along with Pre-exposure prophylaxis, other disciplines of study including Serodiscordant and Seroconversion are integrated into his research.
Serodiscordant is a subfield of Acquired immunodeficiency syndrome that he tackles.
His studies deal with areas such as Interquartile range, Clinical trial, Discontinuation and Pharmacology as well as Emtricitabine.
His Gynecology research incorporates themes from Treatment as prevention and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
